Palatin Technologies
PTN
#10101
Rank
S$31.86 M
Marketcap
S$18.71
Share price
-1.74%
Change (1 day)
1,402.90%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -S$6.57 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$8.84 Million. In 2024 the company made an earning of -S$34.27 Million, an increase over its 2023 earnings that were of -S$41.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$6.57 Million-80.84%
2024 -S$34.27 Million-16.9%
2023 -S$41.24 Million5.99%
2022 -S$38.91 Million-13.7%
2021 -S$45.09 Million33.25%
2020 -S$33.84 Million-172.11%
2019 S$46.91 M2352.33%
2018 S$1.91 M-94.13%
2017 S$32.6 M-154.92%
2016 -S$59.36 Million3.67%
2015 -S$57.26 Million878%
2014 -S$5.86 Million-72.64%
2013 -S$21.4 Million-33.11%
2012 -S$31.99 Million77.71%
2011 -S$18.01 Million
2003 -S$30.49 Million29.93%
2002 -S$23.47 Million36.18%
2001 -S$17.23 Million
1999 -S$14.3 Million6.04%
1998 -S$13.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.21 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.65 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$0.74 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.28 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$84.96 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.15 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$64.3 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$37.51 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$70.67 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA